University of Chicago Pediatric Infectious Diseases

Topics

• Toxoplasma gondii Research Studies 139
• Antibiotic Resistance in Bacteria 22
• Antimicrobial Resistance in Staphylococcus 22
• Pneumonia and Respiratory Infections 14
• Tuberculosis Research and Epidemiology 14
• Bacterial Infections and Vaccines 13
• Antifungal resistance and susceptibility 12
• Kawasaki Disease and Coronary Complications 12
• Bacterial Identification and Susceptibility Testing 11
• Gut microbiota and health 11
• Neutropenia and Cancer Infections 9
• Antibiotic Use and Resistance 8

Most cited

1. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2021 · 310 citations · Barbara Hendrickson

2. Mpox in people with past infection or a complete vaccination course: a global case series.

   The Lancet. Infectious diseases · 2024 · 121 citations · John Flores

3. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.

   Annals of the rheumatic diseases · 2021 · 196 citations · Barbara Hendrickson

4. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative.

   JAMA pediatrics · 2022 · 72 citations · Sarmistha Hauger

5. Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples.

   Nature biotechnology · 2026 · 14 citations · Christopher Lehmann

6. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies.

   The Journal of allergy and clinical immunology · 2023 · 55 citations ·